Methods for enhancing the production of viral vaccines in PKR-de

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 5, 435 692, 435239, 4242061, 4242041, 530350, 536 232, 536 245, 536 252, 536 253, C12N 700, A61K 3912, C07H 2100, C12Q 170

Patent

active

058405658

ABSTRACT:
Methods for enhancing the production of viral vaccines in animal cell culture are described. These methods rely on the manipulation of the cellular levels of certain interferon induced antiviral activities, in particular, cellular levels of double-stranded RNA (dsRNA) dependent kinase (PKR), PKR-deficient cells are obtained by a) transfecting a parent cell line with a PKR antisense polynucleotide; b) unaided uptake into a cell line by culturing said cell line in the presence of a PKR antisense polynucleotide; c) transfection of a parent cell line with a PKR dominant negative mutant; or d) culturing a cell line in the presence of 2-aminopurine. In cell cultures deficient for PKR, viral yield is enhanced by several orders of magnitude over cell cultures with normal levels of these proteins making these cell cultures useful for the production of viral vaccines.

REFERENCES:
patent: Re33164 (1990-02-01), Brown
patent: 4579821 (1986-04-01), Palmiter et al.
patent: 5149531 (1992-09-01), Younger
patent: 5525513 (1996-06-01), Chen
Hovanessian, Ara G., "The double stranded RNA--activated protein kinase induced by interferon:dsRNA-PK," J. Interferon Res., vol. 9(6) :641-7 (1989).
Samuel, Charles E.; Ozato, Keiko, "induction of interferons and interferon-induced genes," Biotherapy (Dortherapy, Neth.), vol. Date 1994, 8(3/4, Cytokine Yearbook, vol. 1), 183-187.
Bowie J.U,. et al., "Deciphering the message in protein sequences: tolerence to amino acid substitutions," Science, 247 (4948) :1306-10 (1990).
Der, S.D., et al., Imvolvement of the double-stranded RNA-dependent kinase PKR in interferon expression and interferon-mediated antiveral activity, Proc. Natl. Acad. Sci. USA, vol. 92:8841-8845 (1995).
Aguzzi et al., Brain Pathology (1994) 4:3-20.
Barber et al., Proc. Natl. Acad. Sci. USA, (1994) 91:4278-4282.
Busby et. al., J. Mol. Biol. (1982) 154:197-209.
Camper et al., Biology of Reproduction (1995) 52:246-257.
Candal et al., Biologicals (1991) 19:213-218.
Chong et al., Embo J. 11:1553-1562.
D'Addario et al., J. Virol. (1990) 64:6080-6089.
Deng et al., Analytical Biochemistry (1992) 200:81-88.
Du et al., Cell (1993) 74:887-898.
Feng et al., Proc. Natl Acad Sci USA (1992) 89:5447-5451.
Galabru et al., J. Biol. Chem. (1987) 262:15538-15544.
Green SR et al., Genes & Development (1992) 6:2478-2490.
Gutterman, Natl. Acad. Sci. (1994) 91:1198-1205.
Hassel et al., Methods (1994) 50:323-334.
Henry et al., J. Biol. Regulators and Homestatic Agents (1994) 8:1:15-24.
Hershey et al., Ann. Rev. Biochem. (1991) 60:717-755.
Jaramillo et al., Cancer Investigation (1995) 13:327-337.
Koromilas et al., Science (1992) 257:1685-1689.
Kumar et al., Natl. Acad. Sci. USA (1994) 91:6288-6292.
Lee et al., Virol. (1993) 193:1037-1041.
Lee et al., Virology (1993) 192:380-385.
MacDonald et al., Critical Reviews Biotech. (1990) 10:155-178.
Maran et al., Science (1994) 265:789-792.
Marcus et al., J. Gen. Virol. (1988) 69:1637-1645.
Matsuyama et al., Cell (1993) 75:83-97.
McCormack et al., Virology (1994) 198:92-99.
McMillan et al., J. Biol. Chem. (1995) 270:2601-2606.
Meurs et al., Cell (1990) 62:379-390.
Meurs et al., Proc. Natl. Acad. Sci. USA (1993) 90:232-236.
Meurs et al., J. Virol. (1992) 66:5805-5814.
Ozes et al., J. Interferon Res. (1994) 14:25-32.
Pearson, Devel. Biol. Standard. (1992) 76:13-17.
Peetermans, J. Vaccine (1992) 10 supp 1:S99-S101.
Pestka et al., Ann. Rev. Biochem. (1987) 56:727-777.
Proud C.G., Trends Biochem Sci. (TIBS), (1995) 20:6:241-246.
Read et al., J. Infect. Dis. (1985) 152:466-472.
Robertson et al., J. Gen. Virol. (1991) 72:2671-2677.
Sen et al., J. Biol. Chem. (1992) 267:5017-5020.
Shevitz et al., in Viral Vaccines Mizrahi, A. ed pp. 1-35 (1990) Wiley-Liss .
Tanaka et al., Adv. Immumol. (1992) 52:263-281.
Tannock et al., Vaccine (1985) 3:333-339.
Taylor et al., Virus Research (1990) 15:1-26.
Thomas et al., J. Immumol. (1993) 150:12:5529-5534.
Visvanathan et al., Embo J. (1989) 8:1129-1138.
Williams, Eur. J. Biochem. (1991) 200:1-11.
Wood et al., Biologicals (1990) 18:143-146.
Zinn et al., Science (1988) 240:210-213.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for enhancing the production of viral vaccines in PKR-de does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for enhancing the production of viral vaccines in PKR-de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancing the production of viral vaccines in PKR-de will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1700947

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.